Gamal Sadat, son of former Egyptian President Anwar Sadat, reflects on his father's pursuit of peace: "He used the power of his presidency to improve the lives of our people."
Genmab shares jumped to an all-time high after an experimental cancer treatment cut the risk of death by 50% in a late-stage trial, adding to a string of positive results that have boosted confidence in the Danish drugmaker’s pipeline.
Genmab shares surged the most in more than six years after its experimental ovarian cancer treatment exceeded analyst expectations in a late-stage trial, boosting confidence in the Danish drugmaker’s pipeline
GENMAB AND ABBVIE SAY EPCORITAMAB IN COMBINATION WITH R-CHOP DEMONSTRATED A STATISTICALLY SIGNIFICANT IMPROVEMENT IN PROGRESSION-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), WITH THE PHASE 3 TRIAL SHOWING A 51% REDUCTION IN THE RISK OF PROGRESSION OR DEATH
Gamma Chief AI Officer Deeni Fatiha, Adobe Director Morgan Prygrocki and Shane Tapp of Salesforce Global Brand Marketing discussed what changes when creative AI moves from experimentation into production.